Case Reports
Every UPC, EPO and national court decision our fee earners have written up — now filterable by the same 40+ tags they already use to classify each report, plus the court and industry sector behind it.
Novartis Pharmaceuticals UK Ltd v Medimmune Ltd & Anor – Self-perpetuating references to the CJEU
Multiple rulings of the CJEU on the SPC Regulation fail to answer questions posed by the national courts, result in greater confusion and give rise to a need for yet more references.
Legitimate to improve your position in litigation by obtaining a new trademark registration – confirmation by UK Court of Appeal
The Court of Appeal has confirmed that it can be acceptable to improve your position in litigation by obtaining a new trademark registration in the period between the start of infringing acts and...
All in the American mind? US and UK take different approaches to assessing mental act exclusions
In a recent EIP newsflash we reported a recent development in the way the UK Intellectual Property Office handles subject matter excluded from patentability, based on a High Court judgement relating...
Have your say: design right protection - effective or not?
In May 2011, a review, entitled “Digital Opportunity: A Review of Intellectual Property and Growth” (commonly known as “The Hargreaves Review”), was commissioned by the Government to assess whether...
All in the Mind? UK High Court Endorses Narrow Criteria for Patentability Exclusion
A recent High Court judgement regarding Halliburton’s Patent Applications ([2011] EWHC 2508 (Pat)) signals a new development in the way the UK Intellectual Property Office (UKIPO) handles subject...
Please try updating your search criteria.
The UPC Newsletter
Get expert insights and the top patent stories delivered straight to your inbox.